Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting

BACKGROUND: Recent large clinical trials show lower rates of late cardiovascular events by extending clopidogrel >12 months after percutaneous coronary revascularization (PCI). However, concerns of increased bleeding have elicited support for limiting prolonged treatment to high-risk patients. OB...

詳細記述

保存先:
書誌詳細
出版年:J Am Coll Cardiol
主要な著者: Thukkani, Arun K., Agrawal, Kush, Prince, Lillian, Smoot, Kyle J., Dufour, Alyssa B., Cho, Kelly, Gagnon, David R., Sokolovskaya, Galina, Ly, Samantha, Temiyasathit, Sara, Faxon, David P., Gaziano, J. Michael, Kinlay, Scott
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578293/
https://ncbi.nlm.nih.gov/pubmed/26337986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2015.06.1339
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料